|
|
 |

Michael Green, Ph.D.
Education/Training
Institution and Location
|
Degree, if applicable
|
Year(s)
|
Field of Study |
Oberlin College, Oberlin, OH
|
B.A.
|
1979
|
Psychobiology |
Cornell University, Ithaca, NY
|
Ph.D.
|
1984
|
Neuropsychology |
University of California, Los Angeles
|
Postdoctoral
|
1986
|
Neuropsychology |
|
A. Positions and Employment
| 1986–1992 |
Assistant Research Psychologist, Psychiatry and
Biobehavioral Sciences, Neuropsychiatric Institute, University
of California, Los Angeles |
| 1991–1997 |
Research Director, Clinical Research Unit, Camarillo State
Hospital, Camarillo CA |
| 1992–1996 |
Associate Professor in Residence, Psychiatry and Biobehavioral
Sciences, Neuropsychiatric Institute, University of California,
Los Angeles |
| 1992–Present |
Health Sciences Specialist, Psychiatry Service, VA Greater
Los Angeles Healthcare System, Los Angeles CA |
| 1996-Present |
Professor In Residence, Psychiatry and Biobehavioral Sciences,
Neuropsychiatric Institute, Geffen School of Medicine, University
of California, Los Angeles |
| 1998-Present |
Executive Board Member and Chief of the Treatment Unit, VA
VISN 22 Mental Illness Research, Education and Clinical Center
(MIRECC), Los Angeles CA |
| 2004-2005 |
President, Society for Research in Psychopathology |
B. Selected peer-reviewed publications (in chronological order).
***From over 130
 |
Green MF. Cognitive remediation in schizophrenia:
Is it time yet? (Special Article) American Journal of Psychiatry,
1993;150:178-187. |
 |
Green MF, Mintz J, Bowen L, Marshall BD, Kuehnel TG, Hayden
JL, Liberman RP. Prediction of haloperidol reduction in treatment
refractory schizophrenia by the span of apprehension. American
Journal of Psychiatry 1993;150:1415-1416. |
 |
Corrigan PW, Wallace CJ, Schade ML, Green MF. Cognitive dysfunctions
and psychosocial skill learning in schizophrenia. Behavior Therapy,
1994;25:5-15. |
 |
Green MF, Hugdahl K, Mitchell S. Dichotic listening during
auditory hallucinations in schizophrenia. American Journal of
Psychiatry, 1994;151:357-362. |
 |
Green MF, Satz P, Christenson CD. Minor physical anomalies
in schizophrenic patients, manic patients, and their siblings.
Schizophrenia Bulletin. 1994;20:433-440. |
 |
Green MF, Bracha S, Satz P, Christenson CD. Preliminary evidence
for an association between minor physical anomalies and second
trimester neurodevelopment in schizophrenia. Psychiatry Research,
1994;53:119-127. |
 |
Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia
and mania: I Specifying a mechanism. Archives of General Psychiatry,
1994;51:939-944. |
 |
Green MF, Nuechterlein KH, Mintz J. Backward masking in schizophrenia
and mania: II Specifying the visual channels. Archives of General
Psychiatry, 1994;51:945-951 |
 |
Kern RS, Green MF, Goldstein MJ. Can we modify an indicator
of vulnerability to schizophrenia? Journal of Abnormal Psychology,
1995;104:385-389. |
 |
Green MF. What are the functional consequences of neurocognitive
deficits in schizophrenia? (Special Article) American Journal
of Psychiatry, 1996;153:321-330. |
 |
Green MF, Nuechterlein KH, Breitmeyer B. Backward masking performance
in unaffected siblings of schizophrenia patients: Evidence for
a vulnerability indicator. Archives of General Psychiatry, 1997;54:465-472. |
 |
Green MF, Marshall BD, Wirshing WC, Ames D, Marder SR, McGurk
S, Kern RS, Mintz J. Does risperidone improve verbal working
memory in treatment-resistant schizophrenia? American Journal
of Psychiatry, 1997;154:799-804. |
 |
Kee KS, Kern RS, Marshall BD, Green MF. Risperidone versus
haloperidol for perception of emotion in treatment-resistant
schizophrenia: preliminary findings. Schizophrenia Research,
1998;31:159-165. |
 |
Green MF. Schizophrenia from a Neurocognitive Perspective:
Probing the Impenetrable Darkness. Boston, Allyn & Bacon;
1998. |
 |
Kern RS, Green MF, Marshall BD, Wirshing WC, Wirshing D, McGurk
S, Marder SR, Mintz J. Risperidone vs. haloperidol on reaction
time, manual dexterity, and motor learning in treatment-resistant
schizophrenia patients. Biological Psychiatry, 1998;44:726-732. |
 |
Green MF, Nuechterlein KH. Should schizophrenia be treated
as a neurocognitive disorder? Schizophrenia Bulletin, 1999;25:309-319. |
 |
Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. Backward
masking in unmedicated schizophrenic patients in psychotic remission:
Suggestive evidence for aberrant cortical oscillations. American
Journal of Psychiatry, 1999;156:1367-1373. |
 |
Loberg EM, Hugdahl K, Green MF. Hemispheric asymmetry in schizophrenia:
A “dual deficits” model. Biological Psychiatry, 1999;45:76-81. |
 |
Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing
WC. Risperidone in Treatment Refractory Schizophrenia. American
Journal of Psychiatry, 1999;156:1374-1379. |
 |
Green MF, Kern RS, Braff DL, Mintz J. Neurcognitive deficits
and functional outcome in schizophrenia: Are we measuring the “right
stuff”? Schizophrenia Bulletin, 2000;26:119-136. |
 |
Green MF, Braff DL. Translating the basic and clinical cognitive
neuroscience of schizophrenia to drug development and clinical
trials of antipsychotic medications. Biological Psychiatry, 2001;49:374-384. |
 |
Green MF. Schizophrenia revealed: From neurons to social interactions.
New York: W.W. Norton; 2001. |
 |
Wiedl KH, Wienobst J, Schottke HH, Green MF, Nuechterlein KH.
Attentional characteristics of schizophrenic patients differing
in learning proficiency in the Wisconsin Card Sorting Test. Schizophrenia
Bulletin, 2001;27:687-695. |
 |
Brekke JS, Kohrt B, Green MF. Neuropsychological functioning
as a moderator of the relationship between psychosocial functioning
and the subjective experience of self and life in schizophrenia.
Schizophrenia Bulletin, 2001;27:697-708, |
 |
Green MF, Marder SR, Glynn SM, McGurk SR, Wirshing WC, Wirshing
DA, Liberman RP, Mintz J. The neurocognitive effects of low-dose
haloperidol: A two-year comparison with risperidone. Biological
Psychiatry 2002;51:972-978. |
 |
Kern, R.S., Liberman, R.P., Kopelowicz, A., Mintz, J. & Green,
M.F. Applications of errorless learning for improving work performance
in schizophrenia. American Journal of Psychiatry, 2002;159:1921-1926. |
 |
Sergi, M.J., & Green, M.F. Social perception and early
visual processing in schizophrenia. Schizophrenia Research, 2003;59,
233-241. |
 |
Green, M.F., Nuechterlein, K.H., Breitmeyer, B. Tsuang, J. & Mintz,
J. Forward and backward visual masking in schizophrenia: Effects
of age. Psychological Medicine, 2003;33:433-442. |
 |
Green, M.F., Mintz, J., Salveson, D., Nuechterlein, K.H., Breitmeyer,
B., Light, G., & Braff, D.L. Abnormal gamma range activity
in schizophrenia: Evidence from visual masking. (2003) Biological
Psychiatry, 2003;53:1113-1119. |
 |
Kee KS, Green MF, Mintz J, Brekke JS. Is emotional processing
a predictor of functional outcome in schizophrenia? Schizophrenia
Bulletin, 2003;29:487-497. |
 |
Green, M.F., Kern, R.S., and Heaton, R.K. Longitudinal Studies
of Cognition and Functional Outcome in Schizophrenia: Implications
for MATRICS. Schizophrenia Research. 2004; 72:41-51. |
 |
Green, M.F., Glahn, D., Engel, S.A., Nuechterlein, K.H., Sabb,
F., Strojwas, M., & Cohen, M.S. Regional brain activity associated
with visual backward masking. Journal of Cognitive Neuroscience.
2005; 17(1):13-23. |
|
|